Related Experiment Video
Updated: Jul 29, 2025
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics
Weidong Fei1, Jingjing Yan1, Xiaodong Wu2
1Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Abstract:
Cancer is generally considered a result of genetic mutations that cause epigenetic changes, leading to anomalous cellular behavior. Since 1970s, an increasing understanding of the plasma membrane and specifically the lipid alterations in tumor cells have provided novel insights for cancer therapy. Moreover, the advances in nanotechnology offer a potential opportunity to target the tumor plasma membrane while minimizing side effects on normal cells. To further develop membrane lipid perturbing tumor therapy, the first section of this review demonstrates the association between plasma membrane physicochemical properties and tumor signaling, metastasis, and drug resistance. The second section highlights existing nanotherapeutic strategies for membrane disruption, including lipid peroxide accumulation, cholesterol regulation, membrane structure disruption, lipid raft immobilization, and energy-mediated plasma membrane perturbation. Finally, the third section evaluates the prospects and challenges of plasma membrane lipid perturbing therapy as a therapeutic strategy for cancers. The reviewed membrane lipid perturbing tumor therapy strategies are expected to bring about necessary changes in tumor therapy in the coming decades.
Insights
Altering cancer cell membranes with nanotechnology offers a promising new therapy. This approach targets tumor lipids to disrupt cancer growth and overcome drug resistance.
Area of Science:
- Oncology
- Nanotechnology
- Biochemistry
Background:
- Cancer arises from genetic mutations and epigenetic changes causing abnormal cell behavior.
- Plasma membrane lipid alterations in tumor cells have emerged as key targets for cancer therapy since the 1970s.
- Nanotechnology advancements provide opportunities to target tumor plasma membranes selectively, minimizing off-target effects.
Purpose of the Study:
- To review the association between plasma membrane physicochemical properties and cancer hallmarks like signaling, metastasis, and drug resistance.
- To highlight current nanotherapeutic strategies for disrupting cancer cell membranes.
- To evaluate the future prospects and challenges of plasma membrane lipid-perturbing cancer therapy.
Main Methods:
- Review of scientific literature on plasma membrane properties in cancer.
- Analysis of nanotherapeutic strategies targeting membrane lipids.
- Evaluation of therapeutic potential and limitations of membrane lipid perturbation.
Main Results:
- Plasma membrane physicochemical properties are intrinsically linked to tumor progression and therapeutic resistance.
- Various nanotherapeutic strategies exist for membrane disruption, including lipid peroxidation, cholesterol modulation, and structural destabilization.
- Targeting membrane lipids offers a viable strategy for cancer treatment.
Conclusions:
- Plasma membrane lipid-perturbing therapy represents a significant advancement in cancer treatment strategies.
- Nanotechnology-based approaches hold great promise for developing effective and targeted cancer therapies.
- Further research and development are expected to refine these strategies for clinical application in the coming decades.
More Related Videos
06:32Author Spotlight: Exploring Plasma Membrane Repair Mechanisms with Innovative Thermoplasmonic Puncturing
Published on: January 19, 2024
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
